Загрузка...
Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia
BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells. Acute myeloid leukemia (AML) has traditionally been treated with multi‐agent chemotherapy, but conventional therapies have not i...
Сохранить в:
| Опубликовано в: : | Cancer Rep (Hoboken) |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941581/ https://ncbi.nlm.nih.gov/pubmed/32671999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1222 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|